title: Nuclear dynamics of parthenogenesis of human oocytes: effect of oocyte aging in vitro.
abstract: We investigated in detail the nuclear kinetics of oocyte activation of aged human oocytes following combined activation treatment with calcium ionophore and puromycin. Two types of oocytes were used: (a) 1-day-old oocytes after 20-24 h retrieval, and (b) 2-day-old oocytes after 44-50 h retrieval. A total of 185 unfertilized aged oocytes, 91 1-day-old and 94 2-day-old oocytes, were fixed at 1, 2, 4, 6 and 8 h after activation treatment and then metaphase II (MII), anaphase or telophase II (A/T II) or pronuclear stage were recorded. We demonstrated that a combined calcium ionophore and puromycin treatment induced a high activation rate in both 1-day-old (95.6%) and 2-day-old oocytes (95.2%). Our results also demonstrated that the nuclear progression was faster in 2-day-old oocytes than in 1-day-old oocytes, although nuclear progression in parthenogenetically activated human oocytes requires the longer time periods compared with ICSI fertilization. It is concluded that combined treatment of the calcium ionophore and puromycin allows a high rate of parthenogenetic activation and the nuclear kinetics of parthenogenetically activated human oocytes appears to be more rapid in in vitro aging oocytes.
authors.affiliation: Department of Obstetrics and Gynecology, Asahikawa Medical College, Midorigaokahigashi, Asahikawa, Japan. ksen@asahikawa-med.ac.jp
authors.forename: Kazuo
authors.initials: K
authors.lastname: Sengoku
authors.forename: Naoyuki
authors.initials: N
authors.lastname: Takuma
authors.forename: Toshinobu
authors.initials: T
authors.lastname: Miyamato
authors.forename: Tomofumi
authors.initials: T
authors.lastname: Yamauchi
authors.forename: Mutsuo
authors.initials: M
authors.lastname: Ishikawa
mesh_terms: D000001:Calcimycin / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects / Q000502:physiology*; D002467:Cell Nucleus / Q000187:drug effects / Q000502:physiology*; D016922:Cellular Senescence / Q000502:physiology*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007476:Ionophores / Q000494:pharmacology; D009865:Oocytes / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010312:Parthenogenesis; D011691:Puromycin / Q000494:pharmacology
chemical_list: D007476:Ionophores; D000001:Calcimycin; D011691:Puromycin